A Multicenter, Non-comparative, Open-labeled, Prospective Study to Evaluate the Efficacy and Safety of Tacrolimus (Prograf) With Steroid in Korean Lupus Nephritis Patients Who Are Non-responders to Steroid Monotherapy.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Tacrolimus (Primary) ; Corticosteroids
- Indications Lupus nephritis; Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms APPLE
- Sponsors Astellas Pharma
- 06 Sep 2016 Status changed from recruiting to discontinued.
- 27 Oct 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 27 Oct 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.